REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Peptide — Educate, Research, Connect

Peptide — Educate, Research, Connect

Vendor intelligence, research tools, and community-driven reviews — everything you need to navigate the peptide landscape with confidence.

Read First Before You Proceed

Featured Vendors

United States

PeptidePure Labs

BPC-157TB-500GHK-Cu
Canada

BioSynth Research

SemaglutideTirzepatideCJC-1295
Sweden

Nordic Peptides

PT-141Melanotan IIIpamorelin

How It Works

01

Browse Vendors

Search our vendor directory, compare vetting scores, and read verified community reviews.

02

Research Tools

Use our dose calculators, cycle trackers, and purity guides to support your research protocols.

03

Join Community

Leave verified reviews, share your stacks, and contribute to the peptide research knowledge base.

Ready to explore?

Join the growing community of researchers using PeptideVault to find trusted vendors and streamline their protocols.